📗 Cite This Artifact
Gene Expression Atlas
Gene Expression Atlas
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Gene Expression Atlas</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>eQTL Tissue</td>
</tr>
<tr>
<td class="label">AP0E</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">CLU</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">CR1</td>
<td>Blood</td>
</tr>
<tr>
<td class="label">TREM2</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>eQTL Tissue</td>
</tr>
<tr>
<td class="label">SNCA</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">LRRK2</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">GBA1</td>
<td>Blood</td>
</tr>
</table>
This page provides a comprehensive reference for gene expression patterns in the brain across neurodegenerative diseases, leveraging data from the Allen Brain Atlas and other comprehensive expression studies. Understanding where genes are expressed in the brain is fundamental to interpreting GWAS findings, identifying cell-type-specific vulnerability, and developing targeted therapies. [@allen2024]
Gene expression patterns reveal which cell types express disease-relevant genes, providing insights into mechanism and potential therapeutic windows. Single-cell RNA sequencing has revolutionized our understanding of cell-type-specific expression in neurodegenerative diseases. [@seaad2023]
--- [@brain2021]
Brain Region Expression Patterns
Alzheimer Disease Expression Signatures
...
Gene Expression Atlas
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Gene Expression Atlas</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>eQTL Tissue</td>
</tr>
<tr>
<td class="label">AP0E</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">CLU</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">CR1</td>
<td>Blood</td>
</tr>
<tr>
<td class="label">TREM2</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>eQTL Tissue</td>
</tr>
<tr>
<td class="label">SNCA</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">LRRK2</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">GBA1</td>
<td>Blood</td>
</tr>
</table>
This page provides a comprehensive reference for gene expression patterns in the brain across neurodegenerative diseases, leveraging data from the Allen Brain Atlas and other comprehensive expression studies. Understanding where genes are expressed in the brain is fundamental to interpreting GWAS findings, identifying cell-type-specific vulnerability, and developing targeted therapies. [@allen2024]
Gene expression patterns reveal which cell types express disease-relevant genes, providing insights into mechanism and potential therapeutic windows. Single-cell RNA sequencing has revolutionized our understanding of cell-type-specific expression in neurodegenerative diseases. [@seaad2023]
--- [@brain2021]
Brain Region Expression Patterns
Alzheimer Disease Expression Signatures
Hippocampal Expression: The [hippocampus](/brain-regions/hippocampus) shows early involvement in AD. Key genes with hippocampal expression include: [@gtex2020]
- [APP](/entities/app-protein): High expression in pyramidal [neurons](/entities/neurons), moderate in interneurons
- [MAPT](/proteins/tau) (Tau): High expression in pyramidal neurons; isoform expression shifts in AD
- [APOE](/proteins/apoe): Expressed in [astrocytes](/entities/astrocytes) and [microglia](/cell-types/microglia-neuroinflammation); APOE4 carriers show altered expression
- [TREM2](/proteins/trem2): Microglia-specific expression; expression increases in AD
- SNCA: Low baseline expression but increases with pathology
- GRN: High expression in microglia; progranulin deficiency leads to [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology
- [C9orf72](/entities/c9orf72): Moderate neuronal expression; hexanucleotide expansions cause toxicity
- NEFL, NEFM (Neurofilament): Released in neurodegeneration; biomarkers
- CLU (Clusterin): Astrocyte expression; clearance of debris
Parkinson Disease Expression Signatures
Substantia Nigra Expression: The substantia nigra pars compacta is selectively vulnerable:
- SNCA: High expression in dopaminergic neurons; aggregation triggers cell death
- LRRK2: Neuronal expression; kinase activity increases in disease
- PARKIN: Ubiquitous but essential in dopaminergic neurons
- PINK1: Mitochondrial expression; loss leads to mitophagy defects
- GBA1: Lysosomal expression; mutations increase PD risk
- DRD1, DRD2: High striatal expression; targets of dopaminergic drugs
- DARPP32: Medium spiny neuron marker; dopamine signaling
Cell Type Expression
Neuronal Expression
- Excitatory neurons: High expression of synaptic proteins, ion channels
- Inhibitory neurons: GABAergic signaling components, calcium-binding proteins
- Dopaminergic neurons: SNCA, LRRK2, tyrosine hydroxylase (TH)
- Cholinergic neurons: Choline acetyltransferase (CHAT), vesicular transporters
- Astrocytes: APOE, [GFAP](/entities/gfap), CLU, excitatory amino acid transporters (EAATs)
- Microglia: TREM2, CX3CR1, CD33, [complement system](/entities/complement-system) components
- Oligodendrocytes: MBP, PLP, myelin-related genes
- Oligodendrocyte precursor cells (OPCs): PDGFRA, NG2 (CSPG4)
Single-Cell Expression Resources
Allen Brain Cell Atlas
The Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) provides single-nucleus RNA sequencing of AD brains:
- Cell type populations: All major neuron and glial types identified
- Disease states: Comparison of AD vs. healthy aging
- Regional coverage: Multiple brain regions including hippocampus, cortex
- Data access: https://portal.brain-map.org/explore/atlases/sea-ad
Key Findings from Single-Cell Studies
Cell-Type Vulnerability in AD
- Upper-layer excitatory neurons show earliest tau pathology
- Oligodendrocyte precursor cells increase proliferation
- Microglia show disease-specific transcriptional states (disease-associated microglia - DAM)
- Astrocytes adopt reactive phenotypes
- Dopaminergic neurons in substantia nigra show mitochondrial dysfunction signatures
- Microglia show chronic activation patterns
- Oligodendrocytes show reduced myelin gene expression
Expression Quantitative Trait Loci (eQTLs)
AD eQTLs
PD eQTLs
Expression-Based Therapeutic Target Identification
Overexpressed Targets
Genes with high brain expression that are also GWAS hits represent priority targets:
Cell-Type Specific Targets
Neuronal targets: Synaptic proteins, ion channels, neurotransmitter receptors Microglial targets: TREM2, CD33, complement components Astrocytic targets: APOE, glutamate transporters Oligodendroglial targets: Myelin genes, cholesterol metabolism
Expression Database Resources
- Allen Brain Atlas: https://portal.brain-map.org/
- Human Cell Atlas: https://www.humancellatlas.org/
- BrainSpan Atlas: https://brainspan.org/
- GTEx Portal: https://gtexportal.org/
- SEA-AD: https://portal.brain-map.org/explore/atlases/sea-ad
- AMP-AD: https://ampadportal.org/
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-gene-expression-atlas |
| kg_node_id | GENEEXPRESSIONATLAS |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-acbe356b3c9e |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-gene-expression-atlas'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-gene-expression-atlas?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Gene Expression Atlas](http://scidex.ai/artifact/wiki-genes-gene-expression-atlas)
http://scidex.ai/artifact/wiki-genes-gene-expression-atlas